Exchange: NYSEMkt·Updated 04:15 PM EST

About NSRX

About

Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

Advertisement|Remove ads.